The Smardii offering is now closed and is no longer accepting investments.

Smardii

A New Standard of Care for Elderlies

Smardii

A New Standard of Care for Elderlies

Miami, FL
Technology
Smardii is a sensor-based wearable solution that transforms any adult incontinence protection into a smart diaper. Our product continuously monitors health conditions, such as the presence and level of urine and stool, the patients’ body positioning for fall detection, and repositioning for pressure ulcers. Smardii is currently in the pre-revenue stage.

$162,803

raised
132
Investors
$12M
Valuation
$2.40
Price per Share
$249.60
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1M
Offering Max
0
Days Left

$162,803

raised
132
Investors
$12M
Valuation
$2.40
Price per Share
$249.60
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1M
Offering Max
0
Days Left
This offering ended on December 09, 2021 and is no longer accepting investments.

Reasons to Invest

Market: long-term care is a trillion-dollar global market, exponentially growing at a cagr of 7.5% (due to baby boomers), and at an accelerated rate since covid-19.
Traction: already 10 long-term care partners signed, plus over $10 million worth of monthly SaaS in our sales funnel (B2B only).
Experienced Team: a very diverse and highly skilled team of scientists, clinicians, and business professionals with over 200 years of combined experience ready to bring this FDA-compliant medical device to the B2B, B2B2C, and B2C markets.

A New Standard Care for Elderlies, At Nursing Homes, or Aging-in-Place

Smardii is advancing the quality and dignity of adult and elder care while providing valuable information for preventative care, improved outcomes, and cost reduction.

Device - exhibited at CES 2020 (consumer version)

Smardii is tackling a global issue which is the exponential increase of the elderly population combined with the lack of nurses to take care of them. 


Nursing homes have been struggling with poor staffing ratios, increased costs and liabilities, lack of resources (financial, technological, manpower), and poor patient outcomes for decades. We all know that the COVID-19 pandemic has even worsened the situation.


That’s where our sensor-based, wearable solution comes in -  transforming any adult incontinence protection into a smart garment that continuously monitors and detects key parameters.


Smardii is currently in the pre-revenue stage.

The Problem


The Long-Term Care Industry is Facing Several Challenges

Incontinence is the starting point of many critical issues in eldercare. Besides losing their dignity, they also become more prone to bedsores and other skin Infections, aggravated urinary tract infections, and lack of sleep. These have proven to negatively impact falls, exacerbation of dementia, and severe cognitive illnesses such as Alzheimer’s


In short: quality of life goes down, while healthcare costs go up.

Unless they have a loved one in a nursing home, most people don’t know that elderlies living in a nursing home are sometimes woken up 4-5 times a night in order to check on their diapers. Especially at an old age, lack of sleep is a serious issue that has many consequences on their physical health and their mental well-being. Imagine being woken up 4-5 times a night! 


In addition, as a result of the pandemic, they are now being manually checked more often in an effort to flag any potential risk of infection or health degradation that could lead to their hospitalization and potentially expose them to COVID-19 cases. Now, operators have to multiply unnecessary contacts by manually checking on residents every 2-3 hours on average. Without technology, there is no other solution for caregivers.

Products related to incontinence already represent more than a third of nursing homes’ spending and with these new protocols, nursing homes spent more time and more money than ever to monitor their residents. This is not economical, not efficient, and not patient-centric.


Despite this, it still doesn’t guarantee that residents will not be in a soiled environment for a long time. If a patient wets or soils their garment shortly after being manually checked, they could remain in that state for several hours.


Furthermore, over the years, the lack of skilled nursing workers has led to a degradation in the quality of care at skilled nursing facilities. The staffing levels at nursing homes have not kept up with the rise in admissions, which leads to increased strain on operations at such facilities across the country producing a potential rise in complaints of abuse, neglect, and overall poor quality of care. 

As a COVID-19 solution, we believe Smardii is now a must-have remote monitoring tool for long-term-care operators who want to improve patient care, while drastically reducing operational spending. See interview from Laurie Dale, Ability Beyond’s Chief Technology Officer below:

When trying to put a dollar amount on some of these issues, we learn that:


  • The exponential increase of the elderly population accompanied by the shortage of nurses and medical staff increases risks and liabilities for healthcare facilities and affects the quality of care

  • Increase in the cost of eldercare due to lack of innovation and lack of automation for certain tasks 

  • Cost of UTIs is $1.6 Billion per year in the U.S.

  • Cost of Falls are $50 Billion per year and 3 deaths per hour in the U.S. for people aged 65+

  • Cost of Pressure Ulcers cost between $10 and $26 Billion per year in the U.S.

  • The average settlement for Nursing Home Neglect/Abuse case in the U.S. amounts to $406,000

  • Covid-19 has put an additional strain on healthcare operators who are now forced to find solutions or they may close down.

The Solution


Smardii. Better Care

Smardii is an IoMT (Internet of Medical Things) medical device that, when attached to any adult brief, is able to detect an array of body functions like urine, stool, and body positioning for fall detection and pressure ulcers monitoring. This is the first generation of our product, already in use at nursing homes, and FDA-compliant.


And, we are on our way to include geolocation, body temperature reading, and real-time urinalysis in an upcoming version (Smardii Gen2, a.k.a. Smardii Plus).

Aside from the obvious quality of care and life improvement for patients, we are also eliminating tedious manual processes for medical staff. This means our solution offers immediate and substantial cost savings for healthcare facilities.


Plus, our technology is also building an entire health history for patients. Healthcare facilities can show clear evidence of the quality of care given or reported to their regulators.


This becomes very important where neglect lawsuits can cost hundreds of thousands (sometimes millions) of dollars to nursing homes. Bedsores being evidence of neglect is difficult to overcome before a court of law, when the caregivers cannot produce compelling evidence. Smardii can help bridge that gap.

gif

How it works


 Intelligent Patient Monitoring

Smardii is made up of the following: 


  • Disposable (single use) Sensor Strips: With an adhesive backing, the sensor strip is attached to the inside of an adult incontinence garment, either a diaper or pull-up brief.

  • The “Puck” - A reusable, rechargeable, and waterproof communication device: The Puck clips onto the outside of the garment and attaches to a protruding tab on the sensor strip. This is the “brains” of the Smardii system. The Puck takes information from the sensor strip and sends it to the Cloud, via a gateway.

  • LoRa Connectivity Gateway: The gateway is simply plugged into a standard electrical outlet, takes information from active Pucks, and sends it to the Cloud.

  • The Smardii Portal: a web-based software that pulls down information from the Cloud. Alerts, preset notifications, and other information can be displayed in graphical or numerical formats on any smart device.

From there all you have to do is:


  1. Plug the Gateway in, and after 3 to 5 minutes, the entire system will go live and automatically connect to our Cloud servers.

  2. Charge the pucks, four hours each. Batteries last for 90 hours.

  3. With a nurse practitioner's help, peel off the adhesive backing the sensor strip and apply it into whatever brand or type of incontinence protection is being used.

  4. Put on the pull-up, with the sensor strip now in it. The sensor strip itself is not touching the skin since it is protected by a biocompatible mesh material. It is disposable, very flexible, very soft, and residents do not notice any difference.

  5. The puck goes outside of the protection and physically clamps onto the sensor strip. After a few seconds, the data will start flowing from the Puck to the Cloud.

gif

Our current version detects the presence of urine, stool, and analyzes body positioning. The key functionalities are:


  • Urine Graph 

  • Urine vs. Stool Event Tracker 

  • Body Positioning for Activity Tracking 

  • A Pressure Ulcers Repositioning Notifier

Smardii goes well beyond incontinence monitoring - It is a health monitoring device and an operational management tool for caregivers.

The Market


The Long Term Care Market is About to Have a Boost

The Long Term Care Market size was valued at USD 751.9 billion in 2019 and is expected to witness 6.9% CAGR from 2020 to 2026.


Increasing aging and life expectancy will continue to boost the market growth during the analysis period. Additionally, advancements in medical technology have allowed caregivers and family members alike to securely diagnose and treat the elderly population base effectively. 


Emerging technologies for the elderly, like Smardii’s, favor the market as over 80% of home-health patients require help with toileting.  

Our market is divided into three main categories:

In general, home health agencies, hospices, and nursing homes all provide nursing or skilled nursing services. It is therefore our target market number one since it is where patients and residents require the most attention and monitoring.

Our Traction


Impressive Achievements

We were working hard behind the scenes until 2019, and since then we've been on a roll, being acclaimed by the medical and the scientific communities, winning awards, and we've been recognized by the press globally.

Check out some our achievements:


  • Elected Top 10 Patient Monitoring Solution 2019 by the Healthcare Tech Outlook Magazine.

  • An entire week of Seamless Live Demo at CES 2020 Las Vegas, where hundreds of people stopped by our booth each day and made contact. 

  • Top 10 Finalist at the NASA iTech Challenge of CES 2020. 

  • Over 70 Press Releases in about 20 countries

  • Formed Strategic Partnerships with various Long Term Care Operators, representing over 25,000 beds, already undersigned Letters of Intent.

  • Another 250,000 beds in our Queue (sales funnel, no purchase order signed yet). 

Highlighted achievement


Our first pilot project has already yielded positive results

The Business Model


We know The Situation is Challenging - Which is Why our Model is Easy, Affordable, And Profitable

The business model is fairly simple because our customers, who are facing many challenges at the moment, need things to be as simple as possible.


That’s why we have a monthly recurring Software as a Service and Hardware as a Service so customers pay a single price below $99 per person all-in.

When it comes to Medicare, we see it as a great incentive for healthcare operators to adopt Smardii, but we believe our solution is already compelling enough. However, with reimbursement from Medicare, customers could possibly get Smardii fully paid for, or even make a profit. Based on a recent study conducted by a third-party reimbursement expert, we believe Smardii is eligible for several CPT Medicare reimbursement codes.


Over time, Smardii will be gathering valuable data, which we intend to monetize while complying with all relevant laws and regulations such as HIPAA, GDPR, and the like.

How We Are Different


Smardii is Safe, Simple Health Monitoring 

Smardii is neither the first nor the last IoMT solution on the market - but we believe it to be the most comprehensive and the most economical out there. 

When it comes to solutions improving daily living, and the well-being of the elderly population, we see that there are plenty of independent solutions for caregivers to choose from. 

Smardii is the most robust, comprehensive, and adult-focused technology out there. We do not use WiFi, BLE, or ZigBee. We are using a private network, built for large-scale medical facilities, and allowing for quick deployment.


Our solution is brand-agnostic, we do not rely on diaper manufacturers, and we do not expect healthcare operators to switch brands and disrupt their procurement process.


Our solution is auto-provisioning, which means there is no equipment installation needed. Even during the peak of the pandemic, we could get our system running with no effort. 


Our solution uses a private network, which means that we do not need to access our customer’s WiFi. This gives them a lot of comfort in terms of cybersecurity, and we do not saturate their WiFi bandwidth.

The Vision


We Want to Give You Cutting-Edge Critical Health Data

Since 2018, Smardii’s strategy has always been to first enter the B2B adult market, get product and vision validation from healthcare professionals, and slowly penetrate the in-home care market (adults-only), with our Gen1 product, then with our Gen2 product, which will include temperature reading and real-time urinalysis. Smardii is presently pre-revenue.


Our mission is to improve the lives of residents, patients, and their caregivers but also to allow elder care facilities to streamline their operations, reduce costs and liabilities using our cutting-edge technology.


Our long-term vision is to gather and provide users and their caregivers with critical health data, for preventative care and improved health. And finally, putting our product into people’s homes, by first partnering with in-home care service companies, IoT monitoring companies, or any other relevant strategic partner (B2B2C adult market). We want people to think that “if nursing homes trust and use Smardii, (we) should do the same for mom and dad at home”.

Since the pandemic, we see an increase in demand from elderlies living at home, and from younger adults with disabilities, who also need Smardii. See here a testimonial from Paul Amadeus Lane, ABC Knet broadcast professional and disability advocate:

A successful crowdfunding campaign could help us enter the B2C market quicker than anticipated. The demand is here!


We see the evolution of Smardii going from Hardware to Software, to Data. This is our 5-year plan. 

During the last 6 months, we were deeply involved in and have finalized COGS reduction and supply chain improvement with world-class medical device contract manufacturers. We have already taken the necessary steps to protect our Intellectual Property for future development and commercial deployment.

OUR LEADERSHIP


An A-Team of  Scientists and Business Professionals

The Smardii Team has over 200 years of combined experience in the corporate world, more specifically in the Life Sciences business. The team is very diverse, with a tremendous track record built at some of the world’s largest companies. 


What makes Smardii different as a startup is that it was not started by inventors or scientists. The early founders were in the Private Equity business before starting Smardii. 

We then decided to build an A-Team of life sciences professionals to carry on this project. 

Why Invest


The Elderly Community Needs Smardii

With the market value, and genuine need for this technology, we feel that our product is revolutionary when it comes to the future of elderly care, we anticipate…


  • Reduction of high-cost medical Issues by up to 48%

  • Reduction of operational costs by up to 41%

  • Reduction of night sleep interruptions by 50%-100%

We are as confident in helping people as we are in being a worthwhile investment. Join us on our journey to disrupt the healthcare system, and provide elderly patients and adults with disabilities what they deserve. 

In the Press

WTin

Smardii diaper aims to ‘revolutionize’ health monitoring

Healthcare Tech Outlook

Smardii: Preventive Care through Smart Adult Pads

NonWovens Industry

Breaking News: Diaper Sensor Technology Launched

Venture Beat

How Tech is Catering to the Elderly and Caregivers

PR Newswire Cision

The global smart diapers market is expected to grow at a CAGR of more than 29% during the period 2018-2024

PCMag

The Amusing World of Fitness and Health Tech at CES 2020

International Business Times

Seniors Get Special Attention At Consumer Tech Show

Yahoo! News

Seniors get special attention at consumer tech show

Cheddar News

It's the Uber of Pooper

Healthcare IT Today

Health and Wellness Was Strong at CES 2020 Unveiled

Sound Health

New "Smart Diaper" for Adults shown at CES

Infobae

Las personas mayores, conectadas de pies a cabeza para seguir saludables

iPro Up

El "Top Ten" de los lanzamientos más insólitos de la feria tecnológica de Las Vegas

The Australian

Annual CES Unveiled Event Showcases Technology of the Future that is Here Right Now

La Presse Canada

Les aînés connectés des pieds à la tête

Windsor Star

Hot products from CES 2020

BFM Business

What's up New York: Smardii conçoit des Couches Connectées

Le Nouvel Obs

Les seniors connectés des pieds à la tête, des couches aux lunettes

FZN

And Humanity Invented the Connected Diaper

Offering Summary


Company

:

Smardii, Inc.

Corporate Address

:

1221 Brickell Avenue, Suite 900, Miami, FL 33131

Offering Minimum

:

$9,998.40

Offering Maximum

:

$999,998.40

Minimum Investment Amount

(per investor)

:

$249.60











Terms


Offering Type

:

Equity

Security Name

:

Class A Common Stock

Minimum Number of Shares Offered

:

4,166

Maximum Number of Shares Offered

:

416,666

Price per Share

:

$2.40

Pre-Money Valuation

:

$12,000,000.00











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the President of the Company, or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the President determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the President for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.

*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Company Perks*

Time-Based:

Friends and Family Early Birds

Invest within the first 72 hours and receive additional 15% bonus shares.

Super Early Bird Bonus

Invest within the first week and receive additional 10% bonus shares.

Early Bird Bonus

Invest within the first two weeks and receive an additional 5% bonus shares.

Lead Investor

Invest $250,000 within the first 2 weeks and receive an additional 20% bonus shares.

 

Amount-Based:

$500+ | Tier 1

Join the priority waitlist to be among the first to receive the Smardii system 

$1,000+ | Tier 2

5% bonus shares + Join the priority waitlist to be among the first to receive the Smardii system

$2,500+ | Tier 3

7% bonus shares + Join the priority waitlist to be among the first to receive the Smardii system 

$5,000+ | Tier 4

9% bonus shares + Join the priority waitlist to be among the first to receive the Smardii system + Meet (virtually) with the Founders to discuss “Smardii Into the Future”.

$10,000+ | Tier 5

12% bonus shares + Join our Clinical/Investor advisory group + 10% discount on Smardii (Outside discounts/margins won’t stack) + Join priority waitlist + invitation to our “Investors Greetings Dinner” (transportation/accommodation costs excluded).

*All perks occur when the offering is completed.

The 10% StartEngine Owners' Bonus

Smardii's will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class A Common Stock at $2.40 / share, you will receive 110 shares, meaning you'll own 110 shares for $240. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.

Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$86,961.00 USD
$175,621.00 USD
Cash And Cash Equivalents
$56,947.00 USD
$154,654.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$1,067,832.00 USD
$123,656.00 USD
Long Term Debt
$102,149.00 USD
$95,169.00 USD
Revenues And Sales
$0.00 USD
$0.00 USD
Costs Of Goods Sold
$0.00 USD
$0.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$2,142,780.00 USD
-$672,981.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

LAST DAY TO INVEST!!!!!!!!!

7 months ago

Hello  Smardii Followers!

This is your LAST DAY to invest in Smardii, so please consider investing now!!!!!

Whether you decide to invest or not, we'd like to thank you for following us and for cheering for us. We hope to have conveyed that we're here with the mission to improve the lives of the many people that are suffering from incontinence and all related medical complications. Our goal is to help our most vulnerable, our loved-ones to get their dignity back, while giving the proper tools to caregivers so that they provide a Better Care to those in need!

Thanks again for your support.

The Smardii Team

PATENT - NOTICE OF ISSUANCE!!!!!!!

7 months ago

Dear Investors, 

It is with great pleasure that Smardii received today a Notice of Issuance from the USPTO for one of its Patent Applications.

It is scheduled to be published on December 14, 2021.

Thanks again for believing in us. And for those who haven't invested just yet, there are 7 days left.... just invest here: www.startengine.com/smardii


9 days left to invest in Smardii

7 months ago

Dear Followers, 

If you are considering investing in Smardii, you have 9 days left...! After that, we'll be busy with other exciting things.

Indeed, our campaign on StartEngine will be closing on Wednesday December 8th, 2021, so please consider investing now!

3 Weeks Left until we Close the Campaign!

8 months ago

It's Now or Never!

Thank you to all of our investors and followers. 

We have enjoyed sharing the Smardii story with you. Now more than ever, we need to focus on execution. Besides helping on the financial side, this crowdfunding campaign had the indirect effect to generate many more customer leads. We need to switch gears and prioritize operations over fundraising activities. 

This is a notice to let you know that our campaign on StartEngine will be closing on Wednesday December 8th, 2021, so please consider investing now!

Please continue to reach out to us with any questions or comments about our company...and thank you so much for your support!  We look forward to hearing from you during these last days of our StartEngine campaign.


Note that an investor may cancel an investment commitment for any reason until 48 hours prior to our close date, unless we have already disbursed your funds previously.

Notice of Funds Disbursement

8 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Smardii has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Smardii be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

Smardii in testing collaboration at the Fraunhofer Institute via Vivai Germany

8 months ago

Smardii is currently collaborating with Germany-based company VIVAI (www.Vivai.care & www.vivai.de) on the testing of the Smardii system in view of a possible pilot roll-out in Germany. The actual testing will be performed in the coming weeks by the Fraunhofer Institute (www.fraunhofer.de).

The Fraunhofer-Gesellschaft, headquartered in Germany, is the world’s leading applied research organization. With its focus on developing key technologies that are vital for the future and enabling the commercial exploitation of this work by business and industry, Fraunhofer plays a central role in the innovation process.


Vivai is one of Germany’s pioneers in Internet of Things as applied to Elder Care. After (unsuccessfully) evaluating several competing products, Vivai has decided to collaborate with us and Fraunhofer in order to possibly bring Smardii to the German/Austrian/Swiss markets. This comes as a critical need to provide an accurate and efficient stool detection solution to eldercare providers in that region which, except for Smardii, did not exist to date.

LARGE DEMAND FROM YOUNGER ADULTS WITH DISABILITIES

9 months ago

Dear Shareholders, 

Since we launched the RegCF Crowdfunding campaign, besides investors' interest, we are also receiving many requests from consumers who have been desperately waiting for a product like Smardii. Elderlies are a big part of our potential users, but there is also (unfortunately) a large demand out there from younger people with disabilities who are struggling with incontinence. 

For instance, in the recent weeks, we’ve heard from parents of 6 years old autist boy, from parents of 14 years old girl with disability, or from quadriplegic adults in urgent need for Smardii. 

It breaks our hearts that we can’t help them immediately. This is one of the reasons why we need your help, as investors, so that Smardii can help the many people who are suffering from incontinence. 

Incontinence suffering has a face: it’s the one of our elderlies and our loved-ones with disabilities.

Below is a video of Paul Amadeus Lane, tech broadcaster, disability advocate and quadriplegic. By listening to him, you will understand the struggles of many people. Watch Paul's Testimonial here. 

 


Invest in Smardii today, and Join us in bringing this industry changing technology to the market!


Notice of Funds Disbursement

9 months ago

[The following is an automated notice from the StartEngine team].

Hello!

As you might know, Smardii has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Smardii be on the lookout for an email that describes more about the disbursement process.


This campaign will continue to accept investments until its indicated closing date.


Thanks for funding the future.

-StartEngine

SECOND TRADEMARK GRANTED

9 months ago

Dear Shareholders, 

We were just granted our second trademark on the Smardii brand. Our brand being registered is another step towards Intellectual Property protection and asset building.

See more info here:

"U.S. Serial Number: 90217666 Mark: SMARDII Owner: Smardii, Inc. Docket/Reference Number: 064461.00001 The USPTO has accepted the Statement of Use filed for the trademark application identified above. The mark will now register and the registration certificate will issue in due course barring any extraordinary circumstances."

Invest in Smardii today, and Join us in bringing this industry changing technology to the market!

PURCHASE ORDER FROM A LARGE U.S. CHAIN OF NURSING HOMES

9 months ago

Hello Shareholders,

We’re delighted to announce that Smardii has secured a Purchase Order from one of the U.S.’ largest chains of nursing homes (top 7). The so-called “Early Access” should start by year-end and equip residents of 3 nursing homes. Our customer has more than 100 locations throughout 4 States and is a prominent player, especially when it comes to Silver Tech. If the customer is satisfied with the Early Access, we hope to subsequently roll-out thousands of residents across multiple States and locations.

This is a Great Win for Smardii, and this crowdfunding campaign is critical for us getting ready to provide services.

Invest in Smardii today, and Join us in bringing this industry changing technology to the market!



Thanks for Confirming your Investment

10 months ago


Dear Shareholders, 

We'd like to thank you for confirming your respective investments.

For those who were unable to reconfirm, we would love for you to consider reinvesting. If you have any questions about your investment status, you can check your Investor dashboard and reach out the StartEngine Investor services team at contact@startengine.com

We're happy to have you back onboard!

FIRST TRADEMARK GRANTED

10 months ago

Dear Shareholders, 

Recently, we were granted our first trademark on the Smardii brand. Our brand being registered is another step towards Intellectual Property protection and asset building.

More information here: https://trademarks.justia.com/878/04/smardii-87804986.html

A second trademark is pending publication. Stay tuned!

Notice of Material Change in Offering

10 months ago

[The following is an automated notice from the StartEngine team].

Hello! Recently, a change was made to the Smardii offering. Here's an excerpt describing the specifics of the change:


Clerical error with the number of outstanding shares of Class B Common Stock. Price per share and minimum investment amount updated.


When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.

PATENT - NOTICE OF ALLOWANCE

11 months ago

PATENT - ANOTHER MILESTONE ACHIEVED!!!

Dear Shareholders, 

It is with great pleasure that Smardii received earlier this week a Notice of Allowance from the USPTO for one of its Patent Applications.

This patent, also filed globally through PCT applications, is instrumental in our continued growth and strategy towards building a digital health device able to improve patients' outcome. Among other things, it protects how we can detect and differentiate between urine and stool which is, as you know, one of Smardii's key differentiators.

Hopefully more patent allowances to come!

Thanks again for believing in us!

Welcome to Smardii!

11 months ago

Dear Shareholders,

Thank you for your investment and Welcome to the Smardii Family! 

With over $160,000 raised in under a week, our campaign already looks very promising, thanks to you!

Our mission is to improve the lives of residents, patients, and their caregivers but also to allow elder care facilities to streamline their operations, reduce costs and liabilities using our cutting-edge technology. A new standard of care is long overdue in this industry. With your help, we are convinced we will forever change the way long-term care operators, and caregivers in general, are providing care to people in need.

Senior Care has a face; it belongs to our parents, grand-parents, and our loved ones. Thanks for supporting us so that together we can take Better Care of people we love!

More exciting updates to come soon! Stay tuned, and don't ever hesitate to reach out to us!

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}